The authors report a case of treatment refractory bulimia nervosa successfully treated with duloxetine, a combined serotonin and norepinephrine reuptake inhibitor, with complete remission of the patient's bingeing and purging behaviours. This case is discussed in the context of existing literature on the psychopharmacology of bulimia nervosa.
Barbarich N C , Kaye W H , Jimerson D (2003) Neurotransmitter and imaging studies in anorexia nervosa: new targets for treatment . Curr Drug Targets CNS Neurol Disord2: 61–72
2.
Brambilla F (2001) Aetiopathogenesis and pathophysiology of bulimia nervosa: biological bases and implications for treatment . CNS Drugs15: 119–136
3.
El-Giamal N , de Zwaan M , Bailer U , Strnad A , Schussler P and Kasper S (2003) Milnacipran in the treatment of bulimia nervosa: a report of 16 cases . Eur Neuropsychopharmacol13: 73–79
4.
El-Giamal N , de Zwaan M , Bailer U , Lennkh C , Schussler P , Strnad A , Kasper S (2000) Reboxetine in the treatment of bulimia nervosa: a report of seven cases . Int Clin Psychopharmacol15: 351–356
5.
Fassino S , Daga G A , Boggio S , Garzaro L , Piero A (2004) Use of reboxetine in bulimia nervosa . J Psychopharmacol18: 423–428
6.
Fava M , Copeland P M , Schweiger U , Herzog D B (1998) Neurochemical abnormalities of anorexia nervosa and bulimia nervosa . Am J Psychiatry146: 963–971
7.
Kaye W , Gendall K , Strober M (1998) Serotonin neuronal function and selective serotonin reuptake inhibitor treatment in anorexia and bulimia nervosa . Biol Psychiatry44: 825–838
8.
Kruger S , Kennedy S H (2000) Psychopharmacotherapy of anorexia nervosa, bulimia nervosa and binge-eating disorder . J Psychiatry Neurosci25: 497–508
9.
Vincent S , Bieck P R , Garland E M , Loghin C , Bymaster F P , Black B K , Gonzales C , Potter W Z , Robertson D (2004) Clinical assessment of norepinephrine transporter blockade through biochemical and pharmacological profiles . Circulation109: 3202–3207
10.
Walsh B T , Fairburn C G , Mickley D , Sysko R , Parides M K (2004) Treatment of bulimia nervosa in a primary care setting . Am J Psychiatry161: 556–561
